Cargando…

BCKDK alters the metabolism of non-small cell lung cancer

BACKGROUND: Metabolic reprogramming is a major feature of many tumors including non-small cell lung cancer (NSCLC). Branched-chain α-keto acid dehydrogenase kinase (BCKDK) plays an important role in diabetes, obesity, and other diseases. However, the function of BCKDK in NSCLC is unclear. This study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yanhui, Xiao, Jiawei, Jiang, Wenna, Zuo, Duo, Wang, Xia, Jin, Yu, Qiao, Lu, An, Haohua, Yang, Lexin, Dumoulin, Daphne W., Dempke, Wolfram C. M., Best, Sarah A., Ren, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743533/ https://www.ncbi.nlm.nih.gov/pubmed/35070754 http://dx.doi.org/10.21037/tlcr-21-885

Ejemplares similares

Aberrant lactate dehydrogenase A signaling contributes metabolic signatures in pancreatic cancer
por: Jiang, Wenna, et al.
Publicado: (2021)

Loss of BCAA catabolism enhances Rab1A-mTORC1 signaling activity and promotes tumor proliferation in NSCLC
por: Xue, Meiting, et al.
Publicado: (2023)

Dataset reporting BCKDK interference in a BCAA-catabolism restricted environment
por: Bravo-Alonso, I., et al.
Publicado: (2016)

Pancreatic stellate cells regulate branched-chain amino acid metabolism in pancreatic cancer
por: Jiang, Wenna, et al.
Publicado: (2021)

Oncogene alterations in non-small cell lung cancer—have we MET a new target?
por: Dempke, Wolfram C. M., et al.
Publicado: (2022)

Phosphorylation of BCKDK of BCAA catabolism at Y246 by Src promotes metastasis of colorectal cancer
por: Tian, Qin, et al.
Publicado: (2020)

Screening for Lipid-Metabolism-Related Genes and Identifying the Diagnostic Potential of ANGPTL6 for HBV-Related Early-Stage Hepatocellular Carcinoma
por: Zuo, Duo, et al.
Publicado: (2022)

BCKDK of BCAA Catabolism Cross-talking With the MAPK Pathway Promotes Tumorigenesis of Colorectal Cancer
por: Xue, Peipei, et al.
Publicado: (2017)

BCKDK Promotes Ovarian Cancer Proliferation and Migration by Activating the MEK/ERK Signaling Pathway
por: Li, Huashun, et al.
Publicado: (2022)

Novel Loss of Function Variant in BCKDK Causes a Treatable Developmental and Epileptic Encephalopathy
por: Boemer, François, et al.
Publicado: (2022)

A Gain-of-Function Mutation on BCKDK Gene and Its Possible Pathogenic Role in Branched-Chain Amino Acid Metabolism
por: Maguolo, Alice, et al.
Publicado: (2022)

Has programmed cell death ligand-1 MET an accomplice in non-small cell lung cancer?—a narrative review
por: Dempke, Wolfram C. M., et al.
Publicado: (2021)

Implications of Polymorphisms in the BCKDK and GATA‐4 Gene Regions on Stable Warfarin Dose in African Americans
por: Bargal, Salma A., et al.
Publicado: (2020)

The Application Value of Lipoprotein Particle Numbers in the Diagnosis of HBV-Related Hepatocellular Carcinoma with BCLC Stage 0-A
por: Zuo, Duo, et al.
Publicado: (2021)

The BCKDK inhibitor BT2 is a chemical uncoupler that lowers mitochondrial ROS production and de novo lipogenesis
por: Acevedo, Aracely, et al.
Publicado: (2023)

APN-mediated phosphorylation of BCKDK promotes hepatocellular carcinoma metastasis and proliferation via the ERK signaling pathway
por: Zhai, Mengying, et al.
Publicado: (2020)

Polymorphisms of ACMSD-TMEM163, MCCC1, and BCKDK-STX1B Are Not Associated with Parkinson's Disease in Taiwan
por: Chang, Kuo-Hsuan, et al.
Publicado: (2019)

BCKDK regulates breast cancer cell adhesion and tumor metastasis by inhibiting TRIM21 ubiquitinate talin1
por: Xu, Chunlan, et al.
Publicado: (2023)

Durvalumab plus novel agents in non-small cell lung cancer—a new COAST on the horizon?
por: Dempke, Wolfram C. M., et al.
Publicado: (2022)

Inhibiting BCKDK in triple negative breast cancer suppresses protein translation, impairs mitochondrial function, and potentiates doxorubicin cytotoxicity
por: Biswas, Dipsikha, et al.
Publicado: (2021)

Efficacy evaluation of surgery combined with chemotherapy for stage IIIA small cell lung cancer patients: a retrospective analysis
por: Bian, Dongliang, et al.
Publicado: (2022)

miR‐495 and miR‐5688 are down‐regulated in non‐small cell lung cancer under hypoxia to maintain interleukin‐11 expression
por: Zhao, Meng, et al.
Publicado: (2020)

Machine learning-based models for the prediction of breast cancer recurrence risk
por: Zuo, Duo, et al.
Publicado: (2023)

Contamination Rate of Cryopreserved Umbilical Cord Blood Is Inversely Correlated with Volume of Sample Collected and Is also Dependent on Delivery Mode
por: Reuther, Susanne, et al.
Publicado: (2022)

Combined immune checkpoint inhibitor and chemotherapy is effective in a patient with ALK rearranged non-small cell lung cancer: a case report
por: Xia, Lexin, et al.
Publicado: (2020)

Treatment of malignant pericardial effusion with (32)P-colloid
por: Dempke, W, et al.
Publicado: (1999)

Application of immune checkpoint inhibitors in EGFR-mutant non-small-cell lung cancer: from bed to bench
por: Jin, Rui, et al.
Publicado: (2020)

Rare thoracic cancers: a comprehensive overview of diagnosis and management of small cell lung cancer, malignant pleural mesothelioma and thymic epithelial tumours
por: Dumoulin, Daphne W., et al.
Publicado: (2023)

Efficacy and Safety of Approved First-Line Tyrosine Kinase Inhibitor Treatments in Metastatic Renal Cell Carcinoma: A Network Meta-Analysis
por: Manz, Kirsi M., et al.
Publicado: (2019)

Bioinformatics Analysis of Expression and Alterations of BARD1 in Breast Cancer
por: Chen, Yong-Zi, et al.
Publicado: (2019)

Immunotherapy in small cell lung cancer: one step at a time: a narrative review
por: Dumoulin, Daphne W., et al.
Publicado: (2021)

Identification of hub genes and their novel diagnostic and prognostic significance in pancreatic adenocarcinoma
por: Zuo, Duo, et al.
Publicado: (2022)

The efficacy of ado-trastuzumab emtansine in patients with ERBB2-aberrant non-small cell lung cancer: a systematic review
por: Huang, Xiu, et al.
Publicado: (2020)

Genetic Alteration and Their Significance on Clinical Events in Small Cell Lung Cancer
por: Jiao, Shuyue, et al.
Publicado: (2022)

Identifying metabolic alterations in newly diagnosed small cell lung cancer patients
por: Pedersen, Shona, et al.
Publicado: (2021)

MicroRNA-29a plays a suppressive role in non-small cell lung cancer cells via targeting LASP1
por: Hu, Zhaolan, et al.
Publicado: (2016)

Defining oligometastatic non-small cell lung cancer: concept versus biology, a literature review
por: Mentink, Jill F., et al.
Publicado: (2021)

Dynamics of cerebrospinal fluid pressure alterations and bilateral transverse–sigmoid sinus morphologies in Asian patients with venous pulsatile tinnitus
por: Hsieh, Yue-Lin, et al.
Publicado: (2023)

Evidence Based Management of Acute Heart Failure in the Era of COVID-19 Pandemic
por: Wang, Lexin
Publicado: (2022)

ILF2 cooperates with E2F1 to maintain mitochondrial homeostasis and promote small cell lung cancer progression
por: Zhao, Meng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_efk0d8v7c08kj97pj9ekumu4as